Literature DB >> 8157046

Protein binding of digitoxin, valproate and phenytoin in sera from diabetics.

J Doucet1, J Fresel, G Hue, N Moore.   

Abstract

Chronic hyperglycaemia results in glycation of serum albumin and might affect the binding of drugs. The aim of the present study was to compare, using an equilibrium dialysis method, the protein binding of therapeutic concentrations digitoxin, valproate and phenytoin in sera from 70 insulin-dependent diabetics and 25 controls. Drug concentrations were measured by fluorescence immunopolarisation. Glycated albumin was measured by laser nephelometry after affinity chromatography. In sera from diabetics, protein binding of digitoxin (88.8 versus 89.9%) was unchanged; the protein binding of valproate (75.2 versus 80.7%) and phenytoin (67.9 versus 75.3%) was significantly decreased, but with no correlation with the concentration of glycated albumin. We conclude that the difference in protein binding between diabetic and control sera is due to glucose-independent modification of albumin in diabetics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8157046     DOI: 10.1007/bf00315318

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

2.  Valproic acid: in vitro plasma protein binding and interaction with phenytoin.

Authors:  J A Cramer; R H Mattson
Journal:  Ther Drug Monit       Date:  1979       Impact factor: 3.681

3.  Nonenzymatic glycosylation of human serum albumin alters its conformation and function.

Authors:  N Shaklai; R L Garlick; H F Bunn
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

4.  Alteration of phenytoin binding by glycosylation of albumin in IDDM.

Authors:  S F Kemp; G L Kearns; C P Turley
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

5.  Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylureas.

Authors:  S Tsuchiya; T Sakurai; S Sekiguchi
Journal:  Biochem Pharmacol       Date:  1984-10-01       Impact factor: 5.858

6.  The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.

Authors:  P J McNamara; R A Blouin; R K Brazzell
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

7.  Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing.

Authors:  W A Kradjan; K A Kobayashi; L A Bauer; J R Horn; K E Opheim; F J Wood
Journal:  J Clin Pharmacol       Date:  1989-12       Impact factor: 3.126

8.  The glycosylation of hemoglobin: relevance to diabetes mellitus.

Authors:  H F Bunn; K H Gabbay; P M Gallop
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

9.  Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.

Authors:  G Gatti; F Crema; G Attardo-Parrinello; P Fratino; F Aguzzi; E Perucca
Journal:  Ther Drug Monit       Date:  1987-12       Impact factor: 3.681

10.  Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatography.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Diabetes       Date:  1980-12       Impact factor: 9.461

View more
  6 in total

1.  Comparison of modification sites formed on human serum albumin at various stages of glycation.

Authors:  Omar S Barnaby; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2010-10-27       Impact factor: 3.786

2.  Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Omar S Barnaby; Chunling Wa; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2010-04-13       Impact factor: 3.786

3.  Estimation of Free Phenytoin Concentration in Critically Ill Patients with Hypoalbuminemia: Direct-measurement vs Traditional Equations.

Authors:  Premila M Wilfred; Sumith Mathew; Binila Chacko; Ratna Prabha; Binu Susan Mathew
Journal:  Indian J Crit Care Med       Date:  2022-06

Review 4.  Review: Glycation of human serum albumin.

Authors:  Jeanethe Anguizola; Ryan Matsuda; Omar S Barnaby; K S Hoy; Chunling Wa; Erin DeBolt; Michelle Koke; David S Hage
Journal:  Clin Chim Acta       Date:  2013-07-24       Impact factor: 3.786

Review 5.  Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients.

Authors:  Muhannad R M Salih; Mohd Baidi Bahari; Arwa Y Abd
Journal:  Nutr J       Date:  2010-12-31       Impact factor: 3.271

6.  Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.

Authors:  Ji-Man Hong; Young-Chul Choi; Won-Joo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.